Glenmark Pharmaceuticals Ltd. made a strong rebound in the second quarter of fiscal year 2020, buoyed by robust growth in its India business. But product roll-outs from a new US site could be vital to fast-track growth of its operations in that key market.
The Indian firm expects its plant in Monroe, North Carolina to go commercial next year, at least the injectables and...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
